Lorenzi Julio C C, Cohen Yehuda Z, Cohn Lillian B, Kreider Edward F, Barton John P, Learn Gerald H, Oliveira Thiago, Lavine Christy L, Horwitz Joshua A, Settler Allison, Jankovic Mila, Seaman Michael S, Chakraborty Arup K, Hahn Beatrice H, Caskey Marina, Nussenzweig Michel C
Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7908-E7916. doi: 10.1073/pnas.1617789113. Epub 2016 Nov 21.
HIV-1-infected individuals harbor a latent reservoir of infected CD4 T cells that is not eradicated by antiretroviral therapy (ART). This reservoir presents the greatest barrier to an HIV-1 cure and has remained difficult to characterize, in part, because the vast majority of integrated sequences are defective and incapable of reactivation. To characterize the replication-competent reservoir, we have combined two techniques, quantitative viral outgrowth and qualitative sequence analysis of clonal outgrowth viruses. Leukapheresis samples from four fully ART-suppressed, chronically infected individuals were assayed at two time points separated by a 4- to 6-mo interval. Overall, 54% of the viruses emerging from the latent reservoir showed gp160 env sequences that were identical to at least one other virus. Moreover, 43% of the env sequences from viruses emerging from the reservoir were part of identical groups at the two time points. Groups of identical expanded sequences made up 54% of proviral DNA, and, as might be expected, the sequences of replication-competent viruses in the active reservoir showed limited overlap with integrated proviral DNA, most of which is known to represent defective viruses. Finally, there was an inverse correlation between proviral DNA clone size and the probability of reactivation, suggesting that replication-competent viruses are less likely to be found among highly expanded provirus-containing cell clones.
感染HIV-1的个体体内存在潜伏的感染性CD4 T细胞库,抗逆转录病毒疗法(ART)无法根除该细胞库。这个细胞库是治愈HIV-1的最大障碍,并且一直难以表征,部分原因是绝大多数整合序列存在缺陷且无法重新激活。为了表征具有复制能力的细胞库,我们结合了两种技术,即定量病毒增殖和对克隆增殖病毒进行定性序列分析。在间隔4至6个月的两个时间点,对来自四名长期接受ART抑制的慢性感染个体的白细胞分离样本进行了检测。总体而言,从潜伏细胞库中产生的病毒中有54%显示出与至少一种其他病毒相同的gp160 env序列。此外,在两个时间点,从细胞库中产生的病毒的env序列中有43%属于相同的组。相同的扩增序列组占前病毒DNA的54%,正如预期的那样,活跃细胞库中具有复制能力的病毒序列与整合的前病毒DNA的重叠有限,其中大部分已知代表缺陷病毒。最后,前病毒DNA克隆大小与重新激活的可能性呈负相关,这表明在高度扩增的含前病毒细胞克隆中不太可能发现具有复制能力的病毒。